Overweight: Clinical Trials

81 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 unknown. 81 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 481Unknown 81

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 81 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LIROH - Liraglutide for Obesity in HIV
Liraglutide - Obesity, HIV Infections
Phase 4UnknownBrigham and Women's Hospital402024-05-022024-05-31
Semaglutide 2.4mg for Low Responders After Bariatric Surgery
Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY] - Obesity, Obesity, Morbid
Phase 4UnknownZuyderland Medisch Centrum1522024-05-012024-03-01
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
Henagliflozin, Placebo - Obese, Weight Loss
Phase 4UnknownThe First People's Hospital of Changzhou3002024-02-152024-01-22
The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty
Esomeprazole - Obesity
Phase 4UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS402024-02-012024-02-28
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
Semaglutide, standard of care - Type 2 Diabetes, Overweight
Phase 4UnknownUniversity Hospital Sestre Milosrdnice602024-02-012024-02-06
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Liraglutide, Orlistat - Non-alcoholic Fatty Liver Disease, Obesity
Phase 4UnknownAffiliated Hospital of Nantong University1022023-11-012024-07-15
Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section
5mg bupivacaine, 10mg bupivacaine - Anesthesia, Obstetric Anesthesia Problems
Phase 4UnknownHospital Civil de Guadalajara1062023-08-012023-09-29
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
Saroglitazar - NAFLD, Obesity
Phase 4UnknownZydus Lifesciences Limited15002023-07-202024-02-07
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL, Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG - PCOS (Polycystic Ovary Syndrome), Semaglutide
Phase 4UnknownPeking University First Hospital752023-05-092024-03-25
Semaglutide and Vascular Regeneration
Semaglutide Pen Injector - Atherosclerosis, Cardiovascular Diseases
Phase 4UnknownCanadian Medical and Surgical Knowledge Translation Research Group1002023-04-292023-07-25
Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
Pregabalin 150mg, Placebo - Obesity, Postoperative Pain
Phase 4UnknownMedical University of Warsaw902023-04-242024-09-19
Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
Naltrexone-Bupropion Combination - Obesity, Morbid, Bariatric Surgery Candidate
Phase 4UnknownZuyderland Medisch Centrum1162023-03-212023-05-30
Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain
Biktarvy, Symtuza - HIV Infections, Obesity
Phase 4UnknownEast Carolina University302023-03-142023-11-14
The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting
Aprepitant, Placebo - Obesity, Nausea and Vomiting, Postoperative
Phase 4UnknownHospital General Tlahuac4002022-12-012023-03-16
Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients
Remimazolam besylate - Remimazolam, Desflurane
Phase 4UnknownSeoul National University Bundang Hospital882022-10-252023-08-14
Efficacy of Oral Semaglutide in Overweight or Obesity
oral semaglutide - Obesity, Weight Loss
Phase 4UnknownAsian Institute of Gastroenterology, India1162022-07-102022-07-20
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
Semaglutide Pen Injector [Ozempic], Very-low Calorie Diet - Type 2 Diabetes Mellitus in Obese
Phase 4UnknownUniversity of Nottingham452021-09-152022-11-04
Empagliflozin and Atrial Fibrillation Treatment
Empagliflozin, Placebo - Atrial Fibrillation, Heart Failure
Phase 4UnknownMiulli General Hospital4002021-09-012021-04-02
The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
Beinaglutide, Dulaglutide - Diabetes Mellitus, Type 2, Overweight or Obesity
Phase 4UnknownSecond Xiangya Hospital of Central South University1202021-05-012023-03-17
A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
Contrave 8Mg-90Mg Extended-Release Tablet, Placebo - Obesity
Phase 4UnknownSt. Joseph's Healthcare Hamilton182021-04-012023-08-03

Showing 20 of 81. Sign in to see all of them.

Narrower conditions

Obesity (69)  ·  Diabetes Mellitus, Type 2 (14)  ·  Obesity, Morbid (9)  ·  Insulin Resistance (5)  ·  Weight Loss (5)  ·  Hypertension (4)  ·  Metabolic Syndrome (4)  ·  Polycystic Ovary Syndrome (4)  ·  Diabetes Mellitus (3)  ·  HIV Infections (3)  ·  Behavior (2)  ·  Glucose Intolerance (2)  ·  Motor Activity (2)  ·  Non-alcoholic Fatty Liver Disease (2)

Broader conditions

Nutrition Disorders (81)  ·  Nutritional and Metabolic Diseases (81)  ·  Overnutrition (81)  ·  Pathological Conditions, Signs and Symptoms (81)  ·  Signs and Symptoms (81)  ·  Body Weight (80)  ·  Metabolic Diseases (27)  ·  Glucose Metabolism Disorders (25)  ·  Endocrine System Diseases (21)  ·  Diabetes Mellitus (15)  ·  Obesity (11)  ·  Urogenital Diseases (9)  ·  Genital Diseases (8)  ·  Hyperinsulinism (8)

Interventions

Liraglutide (8)  ·  Metformin (7)  ·  semaglutide (6)  ·  Exercise (3)  ·  bupropion hydrochloride, naltrexone hydrochoride drug combination (3)  ·  moxonidine (3)  ·  Dexmedetomidine (2)  ·  Diet (2)  ·  Hydroxychloroquine (2)  ·  Naltrexone-Bupropion combination (2)  ·  Orlistat (2)  ·  Simvastatin (2)  ·  Sodium Chloride (2)  ·  empagliflozin (2)  ·  saxagliptin (2)

Sponsors

Universitaire Ziekenhuizen KU Leuven (4)  ·  Baker Heart and Diabetes Institute (2)  ·  Guangzhou General Hospital of Guangzhou Military Command (2)  ·  Ingrid Jazet (2)  ·  Medical University of Warsaw (2)  ·  Royal Perth Hospital (2)  ·  St. Joseph's Healthcare Hamilton (2)  ·  University of Milan (2)  ·  University of Nottingham (2)  ·  Zuyderland Medisch Centrum (2)  ·  Affiliated Hospital of Nantong University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Asian Institute of Gastroenterology, India (1)  ·  Baker Heart Research Institute (1)  ·  Beijing Chao Yang Hospital (1)

Countries

China (9)  ·  Italy (8)  ·  Australia (5)  ·  Netherlands (5)  ·  Poland (5)  ·  Mexico (4)  ·  United States (4)  ·  Canada (3)  ·  Denmark (3)  ·  France (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Greece (2)  ·  India (2)

Top investigators

Jan Tack (3)  ·  Ingrid Jazet, MD (2)  ·  Achille Tolino, MD (1)  ·  Alexandros Kokkinos, MD, PhD (1)  ·  Anand V Kulkarni, MD DM (1)  ·  Anna Casu, MD (1)  ·  Anudeep Katrevula, MD DM (1)  ·  Aristithes G Doumouras, MD (1)  ·  Arnaud De Roover, MD (1)  ·  Ashley M Parrott, PharmD (1)  ·  Asim Shabbir, MBBS (1)  ·  Bertha Torres-Alvarez, MD (1)  ·  Bimin Shi, PHD (1)  ·  Bob Ryder, MD FRCP (1)  ·  Chuwa Tei, MD, PhD (1)

Results publications

PMID 15321413, PMID 16112958, PMID 16443140, PMID 16774830, PMID 18173431, PMID 19439456, PMID 19447599, PMID 19515542, PMID 19656312, PMID 19672175, PMID 20011857, PMID 20035530, PMID 20455872, PMID 21307769, PMID 21334503, PMID 21334504, PMID 21893621, PMID 21932999, PMID 22108086, PMID 22326199, PMID 22451451, PMID 22813360, PMID 23092743, PMID 23135692, PMID 23262963, PMID 23460761, PMID 23765186, PMID 23969793, PMID 23997449, PMID 24030946, PMID 24034832, PMID 24153001, PMID 24362411, PMID 24946047, PMID 25146109, PMID 25201313, PMID 25393047, PMID 25493403, PMID 25650964, PMID 25821536, PMID 25885106, PMID 25936783, PMID 26588260, PMID 26658988, PMID 26692415, PMID 26694495, PMID 26943657, PMID 27574464, PMID 27629425, PMID 27633186

NIH funding

2014 (1), 2015 (1), K23DK125162 (1)